Protalix BioTherapeutics (PLX) EPS (Basic) (2010 - 2026)
Protalix BioTherapeutics (PLX) posted quarterly EPS (Basic) of $0.23 for Q1 2026, up 587.5% year-over-year from $0.03 in Q1 2025, and up 604.69% quarter-over-quarter from -$0.05 in Q4 2025.
Protalix BioTherapeutics (PLX) EPS (Basic) (2010 - 2026) Analysis & Trends
Protalix BioTherapeutics' EPS (Basic) history runs 17 years deep, the most recent figure standing at $0.23 for Q1 2026.
- In Q1 2026, EPS (Basic) rose 587.5% year-over-year to $0.23; the TTM figure through Mar 2026 stood at $0.22 (up 99.85% YoY), while the FY2025 annual figure was -$0.06, down 157.82% from the prior year.
- EPS (Basic) for Q1 2026 stood at $0.23, up from -$0.05 in the prior quarter.
- The five-year high for EPS (Basic) was $0.24 in Q2 2023, with the low at -$0.3 in Q4 2023.
- The 5-year median for EPS (Basic) is -$0.05 (2025), against an average of -$0.01.
- The sharpest annual moves came in 2023 and 2026: EPS (Basic) sank 350.11% in 2023, then jumped 587.5% in 2026.
- Protalix BioTherapeutics' EPS (Basic) stood at -$0.07 in 2022, then tumbled by 350.11% to -$0.3 in 2023, then soared by 149.98% to $0.15 in 2024, then sank by 130.63% to -$0.05 in 2025, then surged by 604.69% to $0.23 in 2026.
- Business Quant data shows PLX's EPS (Basic) at $0.23 in Q1 2026, -$0.05 in Q4 2025, and $0.03 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.82 Bn | 131.97 Bn | 2.84 Bn | 4.34 |
| 2 | Regeneron Pharmaceuticals | 86.70 Bn | 78.71 Bn | 3.93 Bn | 12.62 |
| 3 | Argenx Se | 65.27 Bn | 60.09 Bn | 1.37 Bn | 7.59 |
| 4 | Moderna | 59.18 Bn | 54.04 Bn | 52.00 Mn | -1.96 |
| 5 | BeOne Medicines | 42.11 Bn | 37.01 Bn | 1.53 Bn | 2.12 |
| 6 | Alnylam Pharmaceuticals | 31.80 Bn | 28.49 Bn | 992.69 Mn | 1.23 |
| 7 | BioNTech SE | 28.14 Bn | 9.75 Bn | 668.28 Mn | -0.72 |
| 8 | Insmed | 27.53 Bn | 26.37 Bn | 358.27 Mn | -0.06 |
| 9 | Royalty Pharma | 27.26 Bn | 26.42 Bn | - | 0.18 |
| 10 | Protalix BioTherapeutics | 193.97 Mn | 153.31 Mn | 12.13 Mn | 0.05 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 0.05 |
| Mar 31, 2026 | 0.23 |
| Dec 31, 2025 | -0.05 |
| Sep 30, 2025 | 0.03 |
| Jun 30, 2025 | 0.01 |
| Mar 31, 2025 | -0.05 |
| Dec 31, 2024 | 0.15 |
| Sep 30, 2024 | 0.05 |
| Jun 30, 2024 | -0.03 |
| Mar 31, 2024 | -0.06 |
| Dec 31, 2023 | -0.30 |
| Sep 30, 2023 | -0.03 |
| Jun 30, 2023 | 0.24 |
| Mar 31, 2023 | -0.05 |
| Dec 31, 2022 | -0.07 |
| Sep 30, 2022 | -0.07 |
| Jun 30, 2022 | -0.11 |
| Mar 31, 2022 | -0.05 |
| Dec 31, 2021 | -0.15 |
| Sep 30, 2021 | -0.09 |